Review Article | DOI: https://doi.org/10.31579/2834-5126/020
Theranostic Nanosystem for Targeting Cancer Cells
- Abbaraju Krishna Sailaja 1*
1 (General Medicine), Senior Resident (Cardiology), JNMC, DMIHER, India.
2 (Cardiology), Professor and Head of the Department of Cardiology, JNMC, DMIHER, India.
*Corresponding Author: Abbaraju Krishna Sailaja, Department of pharmaceutics, RBVRR Women’s college of pharmacy, Affilated to Osmania University, Hyderabad, India.
Citation: Abbaraju K. Sailaja, (2023). Theranostic Nanosystem for Targeting Cancer Cells, Clinical Trials and Clinical Research, 2(2); DOI:10.31579/2834-5126/020
Copyright: © 2023, Abbaraju Krishna Sailaja. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 20 February 2023 | Accepted: 28 February 2023 | Published: 06 March 2023
Keywords: theranostic; nanoparticle; stimuli; magnetic field
Abstract
Nanoparticle offer several advantages Background for many application due to its various properties like physical, chemical, biological. Nanotechnology have been use for many purposes like Imaging,Treatment and diagnosis. This multifunctional nano designs is used for targeting cancer therapy by their physiochemical properties they are delivered to target and activate by their internal and external stimuli.The review will focus on chemical design of stimuli response nano system to achieve a tumor targeting. Further more it will enhance the cancer therapy. we will also summarize the smart nano system response to external stimuli like magnetic field, electric field, lightand internal stimuli for targeting tumor. The ranostic Nanosystems have potential for the future disease management. There has been a growing interest in the various kind of theranostic nanoparticle for cancer imaging and therapy in small animals. The ranostic nanoparticle use for diagnostic as well as therapeutic purposes
Introduction
a. Theranostic: Theranostic is a combination of the terms therapeutics and diagnostic. It permit us to diagnose disease in individual and then use identical or closely related agents to treat these diseases [1-3].
b. Nanosystem: Nanoparticle are targeted drug delivery and controlled release of therapeutic agents. This drug delivery system is a modern form which will minimise side effects and also reduce the dosage frequency with lowering the mass of nanoparticle. Thus achieving greater frequency [2].
c. Theranostic Nanosystem: Theranostic nanoparticles are multifunctional nanosystems well designed for specific and personal Theranosticized disease management by virtue of their combining diagnostic and therapeutic capabilities into a single biocompatible, biodegradable particle [1-3].
Theranostic nanoparticles must accumulate rapidly and selectively in target organ of interest, report biochemical and morphologic characteristics of disease, efficiently delivery sufficient drug on demand without damaging healthy organs, clear from the body within hour or be degraded into nontoxic by products [3].
Cancer
Cancer caused by uncontrolled growth of abnormal cells. These cancerous cells called as malignant cells. Cancer occur when genetic material of cell will change which cause result in the growing out of control of the cells. Cancer is one of the disease which caused the level of complexity which demand for the multi-step diagnosis and treatment. Theranostic nanosystem having diagnostic as well as therapeutic activity having the multifunctional property which leads in the treatment of cancer cells and it will detect the cancer cells at the early stage which help to know the Physicianprogression of cancer cells [7-12].
Advantage and disadvantage
Advantage
1.Nanotheranostics having advantage with the nanotechnology in order to diagnose and treat specific disease.
2.It is acting as a multifunctional nanoparticle in particular have been designed for targeted cancer therapy by the usage of various physical and biological stimuli.
3.It is relevant for personalized medicine, allowing detection of disease at early stage.
4.it also improve the safety profile of the given treatment.
5.Nanotheranostics are the agents which will treat the disease at the molecular and cellular level due to which it cause lesser side effects [1-3].
Disadvantage
1.It is a expensive process.
2.Skill is required.
3.Nanotheranostics sometimes for the longer duration it will cause toxicity.
4.Nanotheranostics some of them only got approved some are still under pre-clinical and clinical trials.
5.Selection of the best nanoparticle for the treatment is still a challenging part [7].
Preparation of Nano the ranostics
Theranostic is a combination of therapeutic and diagnostic agent in which nanoparticles is incorporated which show its therapeutic effect for the treatment of cancer. Nanoparticle are the agents used as a controlled drug release to reduce the side effects. Nanoparticles are prepared by several methods. The most commonly used methods are nanoprecipitation, salting out, solvent evaporation, desolvation method etc.
Theranostic is an emerging field of medicine whose name is combination of therapeutic and diagnostic. The idea behind the theranostic is to combine drugs or techniques to simultaneously or sequentially diagnose and treat medical conditions and also monitor response of the patient. Nanoparticle that units the daignostic molecules and drug into a single agent here the nanoparticle act as carrier molecule in the form of drug. A drug for the cancer treatment targeting specific biological pathway in the patient body avoiding damage to the healthy organs and tissues. Once at there target tissue, the nanoparticle produce diagnostic images and delivery their drug [6].
Mechanism and it’s classification
There are various mechanism for the Nanotheranostics delivery:
1.Stimuli responsive stratergies for nanotheranostics delivery:
Nanoscale particles have the ability to accumulate in tumors However, they are required to release the drug or trigger it at predetermined sites for the intended purpose. The nanosystems will enhance drug targeting delivery. It will also increase the local concerntration of drug with in the cancer cells. The stimuli-dependent nanotheranostics systems for cancer theranostics are targeted at cellular environments in a and also ensure the release of drug in a coordinate sequence.[1].
2.stimuli responsive nanotheranostics
2.1pH sensitive Nanotheranostics:-
This nanotheranostics is used for triggering the drug Carrier. When pH induced zno will generate O2 species in cellular medium where fluorescence imaging can be done. The green fluorescent nanowires which is used for targeting cancer cells in this study it was observed that signal of fluorescence zno nanowires was lower at third hour as compared with the first hour as it was showing possible dissolution of nanowire in acidic medium.
It was observed that dissolution of drug in the tumor changes gradually which is absorbed by green fluorescence.[1].
2.2Enzyme linked Nanotheranostics
Enzymes are the biological catalyst which is designed for the high specificity for therapy and diagnosis purposes.
Case study 1:- In this FRET (forester response energy transfer ) combination with nanosystem was designed consist of lysine junction covalent linkage which involve combination of doxorubicin fluorescent Drug with response to lysosomal cat B which is efficient theranostic. It showed that nanosystem can be a promising candidate for Nanoscale enzyme based delivery in the combination of cancer treatment and diagnosis. Therefore, enzyme based theranostics system can exhibit desirable technique to make better theranostic clinical candidate in the future.[1].
3. Magnetic Nanotheranostics
It is one of the most efficient way of physical stimuli drug delivery system. It will work in the presence of magnetic field. Magnetic nanoparticles consist of multilayered which have ability to diagnose and imagine which further act as a drug carrier. It is layered with lactoferrin as a cap with mesoporous iron oxide nanoparticle which enhance deeper penetration to the tumour.
It consists of gas generated molecules perfluoro hexane anticancer drug paclitaxel the combination of lactoferrin magnetic iron oxide nanoparticle cause bursting generation of gas where drug delivery occur upon magnetic field exposure. In vitro study showed that a short exposure of magnetic field can cause intense heat which cause increase in the local pressure and it will damage three dimensionally tumor to increase the drug localization [1-6].
4. Novel material
Carbon nanotubes (CNTs) has gained much interest due to their efficiency in delivering theranostic load into cellular compartments, Various findings have speculated that the translocation of CNT-based systems through the cell membrane usually follows a pH-independent passive process. Theranostic prodrug which was based on multi-walled carbon nanotubes (MWCNTs), strategically decorated with a fluorochrome and anticancer agent (methotrexate, MTX). An independent cytoplasmic delivery of the theranostic prodrug via cellular pathway was observed.
CNT drug delivery systems can be used to deliver theranostic agents into the cytoplasm.Carbon nano-based theranostic delivery with surface functionalization to ensure specific targeting to tumor cells while relying on drug penetration effect the release of carbon nanomedicine will enhance delivery of theranostic system for cancer therapy (1-4)
5. Nanotheranostics for circulating tumor cells (CTCS):
It was estimated that 90% of cancer death occur due to circulating tumor cells. A novel strategy was developed for both diagnostic and therapeutic purposes where gold nanotube will coated with the peg and with folate.A spericalmagnetic nanoparticle is coated with peg and their amphiphilic polymer was conjugated with amino acid and fragment of Eurokinase plasminogen activator receptor is added a mixture of (ATFuPAR)and magnetic nanoparticle. This was injected IV into targeted circulating tumor and it was successfully targeted circulating tumor cells.[1].
Application
1. Theranostic nanomedicine
Theranostic nanomedicine is a combination of Diagnostic and therapy activity. Some popular nanomedicine example gold nanoparticle, magnetic or carbon nanotube are mostly used as a an advanced theranostatic system will recognize specific target bind and will give its action.[13]
2. Combinational delivery approaches
This delivery will enhance the effectiveness of cancer through IV it involved mainly multiple chemotherapeutic drugs and Co delivery of chemotherapeutic drug [9-12].
3. Liposomal delivery system
Liposome are closed bilayer structure which consist of water insoluble polar lipid that is used to encapsulate the drugand target theabnormal cell by protected their bioactivity.Liposomal is a good choice for drug carrier system currently available liposomal formulation for drug carrier system. Currently available several liposomal formulation for cancer therapy is doxorubicin (doxil), daunorubicin [8-13].
4. Ultrasonic image guided therapy
Nanobubble will enhance permeability of cell and cause increase in the drug delivery system the doxorubicin containgnanoemulsion which is made up from perflurocarbon nano dropelets Stabalize by biodegradable copolymer micelles.
This group showed that the release of encapsulated drugs can be achieved and can enhance tumor-specific drug uptake, along with the ability for real-time imaging using ultrasonography. These Nano agents showed both ultrasound and fluorine properties, allowing for multimodal monitoring of delivery and bio distribution through ultrasonography. [9-13].
5.Carbon nanotubes drug delivery:
CNTs can be single-walled or multi-walled, and can be used in multifunctional applications, including photoacoustic imaging, bio sensing and cancer cell detection, drug delivery, and photothermaltherapy.
In drug delivery applications, CNTs are able to enter cells and even cell nuclei thanks to their small size, and they can be functionalized with different moieties in their inner and outer surfaces for targeting and conjugation. The single-walled CNTs conjugated to the chemotherapy drug paclitaxel showed 10 times higher tumor uptake than for the free drug in a breast cancer model [10-13].
Challenging and future direction
Theranostic Nano system can be a best approach for future as novel approach. But many major challenging must be overcome such as selection of best nanomedicine, efficacy, high reproducibility.It shows high sensitivity and quantification of PET imaging, radiolabeling where FDA approved therapeutic nanoparticle example liposomal doxorubicin which shows highly strategy to visualize and accurately biodistribution and pharmokinetic property of nanoparticle.
Nanoparticle with therapeutic and imaging such as gold nanoparticles will be another way to develop future theranostic nanosystem for active targeting tumor cells. Even research shows that a well designed nanosystem in vivo to amplify cancer targeting efficacy. Such concept of vivo targeting hold a great potential for improving tumor targeting capability and may become one of the most interesting research direction for over next 5 years. This is the growing interest in developing theranosticnanosystem for even smarter cancer therapy.
Conclusion
Cancer is a lethal disease that is prevalent all over the world. The biology of cancer has largely been understood by advanced scientific practices. Conventional cancer diagnostic and therapeutic procedures have failed to eradicate cancerous cells effectively from the body. Moreover, From past years Nano therapy is solving many issues related to conventional chemotherapeutic.Nanotheranostics has been combined solution for all issues related to cancer imaging and treatment. Nanomedicine has come with advance nanosystem. It has huge potential to reduce multidrug resistance and enhance selectivity and solubility of nanoparticles. It is evident that the efficacy of nanoparticles depends on their size, surface charge, surface area, and multipotency. Nanoparticles for effective drug delivery need to be stable, easy to fabricate, biocompatible, biodegradable, and nontoxic and possess a capability to release the loaded drug to only targeted site with minimum side effects. Tumor heterogeneity is a major challenge in the development of nanomedicines for targeted delivery in the remedy of cancer. Nevertheless, many such Nano formulations are in clinical trial phase and there is need for more preclinical models so that their targeting effectiveness could be tested. Multiscale modeling and computational models should be used for designing of nanoparticles in order to escalate more advanced targeted drug delivery.
References
- Kang H, Hu S, Cho MH, Hong SH, Choi Y, Choi HS.Thernostic nanosystem for targeting cancer therapy Nano Today. 2018 Dec;23:59-72. Doi: 10.1016/j.nantod.2018.11.001. Epub 2018 Nov 16. PMID: 31186672; PMCID: PMC6559746.
View at Publisher | View at Google Scholar - Jordi Llop* and TwanLammers. Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics @ 2021, 15, 11, 16974–16981 doihttps://doi.org/10.1021/acsnano.1c09139
View at Publisher | View at Google Scholar - Zhen Fana, Peter P. Fub, HongtaoYua, Paresh C. Raya. Theranostic nanomedicine for cancer detection and treatmentjournal of food and drug analysis.(2014; 22 : 3-17
View at Publisher | View at Google Scholar - Vijay SagarMadamsetty, Anubhab Mukherjee and Sudip Mukherjee. Recent Trends of the BioInspired Nanoparticles in Cancer Theranostics.2019;page1-12
View at Publisher | View at Google Scholar - Alexandra Sneider, Derek VanDyke, ShaileePaliwal, Prakash RaiRemotely Triggered Nano-Theranostics For Cancer Applications Nanotheranostics 2017, Vol. 1, Issue 1 1 Review Ivyspring International Publisher Nanotheranostics 2017; 1(1): 1-22.
View at Publisher | View at Google Scholar - Zhe Cheng1†, Maoyu Li1,2†, Raja Dey3 and YonghengChen. Nanomaterials for cancer therapy: current progress and perspectives. Journal of hematology and oncology.2021
View at Publisher | View at Google Scholar - Yihan Yao1†, Yunxiang Zhou1†, Lihong Liu2, Yanyan Xu3,4, Qiang Chen1, Yali Wang1, Shijie Wu5, Yongchuan Deng1, Jianmin Zhang6 and Anwen Shao6.Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. 193 Frontiers in Molecular Biosciences. August 2020; Volume 7: Page 1 to 7 Article
View at Publisher | View at Google Scholar - Shreelaxmi Gavas1, Sameer Quazi2 and Tomasz M. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscal research letter 2021 page 1 -21
View at Publisher | View at Google Scholar - Dienst A., Grunow A., Unruh M., Rabausch B., Nör J. E., Fries J. W., et al. Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins. J. Natl. Cancer Inst. 2005;97: 733–747.
View at Publisher | View at Google Scholar - Cirillo G., Vittorio O., Kunhardt D., Valli E., Voli F., Farfalla A., et al. Combining Carbon Nanotubes and Chitosan for the Vectorization of Methotrexate to Lung Cancer Cells. Materials. 2019; 12:2889.
View at Publisher | View at Google Scholar - Cortes J., Saura . Nanoparticle albumin-bound (nab (TM))-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer. EJC Suppl. 2010;8: 1-10.
View at Publisher | View at Google Scholar - Guo Y., Wang D., Song Q., Wu T., Zhuang X., Bao Y., et al. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. ACS Nano.2015 9: 6918-6933.
View at Publisher | View at Google Scholar - Jing X., Yang F., Shao C., Wei K., Xie M., Shen H., et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer.2019 18:157. 10.1186/s12943-019-1089-9
View at Publisher | View at Google Scholar